Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer.

Kim MJ, Yeo SG, Kim ES, Min CK, Se An P.

Oncol Lett. 2013 Mar;5(3):840-844. Epub 2012 Dec 18.

PMID:
23426072
[PubMed]
Free PMC Article
2.

Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.

Lanni TB Jr, Grills IS, Kestin LL, Robertson JM.

Am J Clin Oncol. 2011 Oct;34(5):494-8. doi: 10.1097/COC.0b013e3181ec63ae.

PMID:
20805737
[PubMed - indexed for MEDLINE]
3.

Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.

Taremi M, Hope A, Dahele M, Pearson S, Fung S, Purdie T, Brade A, Cho J, Sun A, Bissonnette JP, Bezjak A.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):967-73. doi: 10.1016/j.ijrobp.2010.12.039. Epub 2011 Mar 4.

PMID:
21377293
[PubMed - indexed for MEDLINE]
4.

A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.

Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Wilbert J, Xiao Y, Belderbos J.

J Thorac Oncol. 2012 Sep;7(9):1382-93. doi: 10.1097/JTO.0b013e318260e00d.

PMID:
22843086
[PubMed - indexed for MEDLINE]
5.

Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience.

Low JSh, Koh WY, Yap SP, Fong KW.

Ann Acad Med Singapore. 2007 Sep;36(9):778-83.

PMID:
17925989
[PubMed - indexed for MEDLINE]
Free Article
6.

Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?

Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751. Epub 2010 Jul 16.

PMID:
20638194
[PubMed - indexed for MEDLINE]
7.

Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.

Videtic GM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):344-9. doi: 10.1016/j.ijrobp.2009.05.004. Epub 2009 Sep 18.

PMID:
19765913
[PubMed - indexed for MEDLINE]
8.

Radiotherapy for hilar or mediastinal lymph node metastases after definitive treatment with stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer.

Manabe Y, Shibamoto Y, Baba F, Murata R, Yanagi T, Hashizume C, Iwata H, Kosaki K, Miyakawa A, Murai T, Yano M.

Pract Radiat Oncol. 2012 Oct-Dec;2(4):e137-43. doi: 10.1016/j.prro.2011.11.007. Epub 2011 Dec 29.

PMID:
24674177
[PubMed]
9.

Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer.

Yu HM, Liu YF, Yu JM, Liu J, Zhao Y, Hou M.

Radiother Oncol. 2008 Apr;87(1):29-34. doi: 10.1016/j.radonc.2008.01.008. Epub 2008 Jan 30.

PMID:
18237795
[PubMed - indexed for MEDLINE]
10.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
[PubMed - indexed for MEDLINE]
11.

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R.

J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4.

PMID:
19414667
[PubMed - indexed for MEDLINE]
Free Article
12.

Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.

Zimmermann FB, Geinitz H, Schill S, Grosu A, Schratzenstaller U, Molls M, Jeremic B.

Lung Cancer. 2005 Apr;48(1):107-14. Epub 2004 Dec 19.

PMID:
15777977
[PubMed - indexed for MEDLINE]
13.

Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.

Salazar OM, Sandhu TS, Lattin PB, Chang JH, Lee CK, Groshko GA, Lattin CJ.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):707-15. doi: 10.1016/j.ijrobp.2008.01.054. Epub 2008 May 1.

PMID:
18455322
[PubMed - indexed for MEDLINE]
14.

Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.

Onishi H, Kuriyama K, Komiyama T, Tanaka S, Sano N, Marino K, Ikenaga S, Araki T, Uematsu M.

Lung Cancer. 2004 Jul;45(1):45-55.

PMID:
15196734
[PubMed - indexed for MEDLINE]
15.

Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.

Dworzecki T, Idasiak A, Syguła D, Dworzecka U, Suwiński R.

Neoplasma. 2012;59(1):114-20.

PMID:
22103905
[PubMed - indexed for MEDLINE]
16.

Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.

Holt A, van Vliet-Vroegindeweij C, Mans A, Belderbos JS, Damen EM.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1560-7. doi: 10.1016/j.ijrobp.2010.09.014. Epub 2011 Feb 6.

PMID:
21300461
[PubMed - indexed for MEDLINE]
17.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
[PubMed - indexed for MEDLINE]
18.

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.

Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H, Lewensohn R.

Acta Oncol. 2006;45(7):787-95.

PMID:
16982541
[PubMed - indexed for MEDLINE]
19.

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J.

J Clin Oncol. 2006 Oct 20;24(30):4833-9.

PMID:
17050868
[PubMed - indexed for MEDLINE]
Free Article
20.

FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.

Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, Timmerman RD, McGarry RC.

Lung Cancer. 2007 May;56(2):229-34. Epub 2007 Mar 13.

PMID:
17353064
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk